ARESTIN MICROSPHERES 1 MG / 4 MG
MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE) : 1 MG / 4 MG · DIN 02278219 · ORA PHARMA INC.
Health Canada status: MARKETED
What is ARESTIN MICROSPHERES?
ARESTIN MICROSPHERES 1 MG / 4 MG contains MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE) : 1 MG / 4 MG. It is listed in the Health Canada Drug Product Database under DIN 02278219, held by ORA PHARMA INC., supplied as POWDER (EXTENDED RELEASE) for SUBGINGIVAL administration. Health Canada currently lists it as marketed, status dated 20-Jan-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ARESTIN MICROSPHERES used for?
ARESTIN MICROSPHERES (minocycline hydrochloride) is indicated as an adjunct to scaling and root planning (SRP) procedures to decrease pocket depth (PD) in adult patients with chronic periodontitis. ARESTIN MICROSPHERES is administered with SRP to help further reduce PD in the treatment of adult patients with moderate to advanced chronic periodontal disease. ARESTIN MICROSPHERES may be used as part of a periodontal maintenance program which includes good oral hygiene and SRP.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02278219 |
|---|---|
| Brand name | ARESTIN MICROSPHERES |
| Generic / active ingredient | MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE) : 1 MG / 4 MG |
| Manufacturer | ORA PHARMA INC. |
| Strength | 1 MG / 4 MG |
| Dosage form | POWDER (EXTENDED RELEASE) |
| Route of administration | SUBGINGIVAL |
| Schedule | Prescription |
| ATC code | A01AB23 MINOCYCLINE |
| AHFS class | 52:04.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 20-Jan-2011 |
| Original market date | 2008-07-27 00:00:00 |
How is it stored and handled?
null
How is it supplied?
12 cartridges are packaged in one tray with desiccant in a heat-sealed foil laminate resealable pouch. Each cartridge contains 4 mg of powder made up of minocycline hydrochloride and poly (glycolide - co - DL-lactide), PGLA. There is one pouch (total of 12 units) or two pouches (total of 24 units) in each box.
Who else supplies MINOCYCLINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MINOCYCLINE appears in 39 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.